August 9, 2024- Meditech has launched a new nationwide health information exchange network for its U.S. customers base. Traverse Exchange will allow participating Meditech customers to share health data with each other, as well as with organizations using different EHR vendors and exchange networks that adhere to interoperability standards, according to Becker's … [Read more...]

August 9, 2024- Dr. Ziegler and Cory Couch, M.D., orthopedic surgeon at Mayo Clinic in Rochester, Minnesota, are the only two Mayo Clinic surgeons who have implanted smart knee replacements in patients. They will become widely available after Mayo Clinic's trial period of the technology. Dr. Ziegler recently became the first surgeon in the health system to begin utilizing … [Read more...]

August 9, 2024- Medtronic plc announced the U.S. Food and Drug Administration (FDA) approval for its Simplera™ continuous glucose monitor (CGM) — the company's first disposable, all-in-one CGM that's half the size of previous Medtronic CGMs. The discreet design simplifies the insertion and wear experience, eliminating the need for overtape. The Simplera™ platform featuring … [Read more...]

August 9, 2024- Owens & Minor, Inc. reported financial results for the second quarter ended June 30, 2024. According to Edward A. Pesicka, President & Chief Executive Officer of Owens & Minor, “our second-quarter performance is consistent with our expectations, as we are in the early stages of implementing our long-term strategy discussed at Investor Day in December … [Read more...]

August 9, 2024- Wall diagnostic systems have revolutionized the way healthcare providers manage patient care. These systems, typically mounted on the walls of examination or acute care patient rooms, consolidate essential diagnostic tools into a single, organized unit. Wall diagnostic systems are comprehensive units that organize medical diagnostic devices in a single, … [Read more...]

August 8, 2024- Thermo Fisher Scientific Inc. announced that itsSeCore™ CDx HLA A Sequencing System has been granted 510(k) clearance by the United States Food and Drug Administration (FDA) for use as a companion diagnostic with TECELRA® (afamitresgene autoleucel), Adaptimmune’s newly approved T-cell receptor (TCR) therapy for the treatment of adults with unresectable or … [Read more...]

August 8, 2024- Abbott announced a unique global partnership with Medtronic to collaborate on an integrated continuous glucose monitoring (CGM) system based on Abbott's most advanced, world-leading FreeStyle Libre technology that will connect with Medtronic's automated insulin delivery (AID) and smart insulin pen systems. The integration of Abbott's CGM sensor with … [Read more...]

August 8, 2024-  The US Oncology Network (The Network), announced that Tennessee Cancer Specialists (TCS) has joined The Network, effective August 1, 2024. The Network is supported by McKesson Corporation, allowing TCS to benefit from a comprehensive suite of solutions and services. The practice is the largest community-based oncology provider in eastern Tennessee and the third … [Read more...]

August 8, 2024- Ethicon, a Johnson & Johnson MedTech company, announced that the U.S. Food & Drug Administration (FDA) has approved a label update to expand the availability of the LINX™ Reflux Management System to include patients with Barrett’s esophagus (BE) experiencing gastroesophageal reflux disease (GERD) symptoms. The decision is based on a … [Read more...]

August 8, 2024- Bridge Healthcare by Pelstar LLC announces a new group purchasing agreement with Premier, Inc., effective August 1, 2024. This agreement represents a significant milestone for Bridge Healthcare, broadening its reach within the healthcare community. Over the next three years, Premier members will benefit from exclusive pricing and pre-negotiated terms on Bridge … [Read more...]